Monday, May 01, 2023 2:43:26 PM
Pillsworth needs to show activity and show income from that activity.
The annual report just didn't do that.
The shell risk designation must have been a shocker for Pillsworth, after the months, years of trying to get the CE removed.
OTCM is playing hard ball with CCTL.
Until CCTL starts functioning like a company in operation, that CE is going to stay on.
It's ashame, because there are so so many OTC pinkies that look worse than CCTL, but they don't have a caveat empter designation to get off.
One thing is is probably true, CCTL still has a long way to go to get that CE off.
AIMHO
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM